"Tumor Microenvironment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth.
Concept/Terms
Tumor Microenvironment- Tumor Microenvironment
- Microenvironment, Tumor
- Microenvironments, Tumor
- Tumor Microenvironments
Below are MeSH descriptors whose meaning is more general than "Tumor Microenvironment".
Below are MeSH descriptors whose meaning is more specific than "Tumor Microenvironment".
This graph shows the total number of publications written about "Tumor Microenvironment" by people in Harvard Catalyst Profiles by year, and whether "Tumor Microenvironment" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 2 | 5 | 7 |
2011 | 7 | 19 | 26 |
2012 | 12 | 32 | 44 |
2013 | 13 | 30 | 43 |
2014 | 23 | 31 | 54 |
2015 | 37 | 31 | 68 |
2016 | 34 | 52 | 86 |
2017 | 33 | 69 | 102 |
2018 | 38 | 65 | 103 |
2019 | 63 | 117 | 180 |
2020 | 48 | 132 | 180 |
2021 | 54 | 158 | 212 |
2022 | 22 | 215 | 237 |
2023 | 7 | 218 | 225 |
2024 | 1 | 56 | 57 |
Below are the most recent publications written about "Tumor Microenvironment" by people in Profiles.
-
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival. J Immunother Cancer. 2024 Apr 09; 12(4).
-
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy. Cancer Immunol Res. 2024 Apr 02; 12(4):400-412.
-
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clin Cancer Res. 2024 Apr 01; 30(7):1281-1292.
-
Swine pseudorabies virus attenuated vaccine reprograms the kidney cancer tumor microenvironment and synergizes with PD-1 blockade. J Med Virol. 2024 Apr; 96(4):e29568.
-
Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment. Cancer Res. 2024 Apr 01; 84(7):965-976.
-
MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge Weber syndrome. Acta Neuropathol Commun. 2024 Mar 26; 12(1):47.
-
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment. Cancer Res Commun. 2024 Mar 26; 4(3):919-937.
-
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy. Nat Immunol. 2024 Apr; 25(4):644-658.
-
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer. Oncotarget. 2024 Mar 19; 15:238-247.
-
CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness. Sci Adv. 2024 Mar 15; 10(11):eadh9547.